In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

In this GEN webinar, Dave Lahr, PhD, Senior Director of Bioinformatics at Foghorn Therapeutics, discusses chromatin regulation and epigenetic mechanisms that shape transcriptional responses to ...

Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.. If you have the appropriate software installed, you can ...

Please discuss the class and complete drug profile of amyloid-targeting therapies for Alzheimer disease, including their mechanisms of action, efficacy, and safety profiles.

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia ...

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen ...

Antiviral COVID-19 treatments are effective against Omicron The researchers studied the sensitivity of Omicron and Delta to several antiviral treatments with different mechanisms of action.

Lenzilumab binds to and neutralizes GM-CSF, consequently improving outcomes for patients hospitalized with COVID-19.

Lenzilumab significantly improved survival without the need for invasive mechanical ventilation among patients hospitalized with COVID-19, according to results of the LIVE-AIR trial published in ...

The Food and Drug Administration (FDA) has declined the Emergency Use Authorization request for lenzilumab for the treatment of hospitalized patients with COVID-19.

Humanigen has announced that its antibody lenzilumab increased the likelihood of survival among certain Black and African American patients with COVID-19.Lenzilumab is a novel, first in-class ...